Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
Greenwich LifeSciences received a formal notice from Nasdaq for failing to file its Form 10-Q for the quarter ended March 31, 2026. The non-compliance relates to Listing Rule 5250(c)(1), which mandates timely filing of periodic financial reports with the SEC.
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.